APA (7th ed.) Citation

Chen, T., Lin, C., Yeh, D., Tseng, L., Rau, K., Chen, B., . . . Lu, Y. (2023). Anti-tumor efficacy of a bevacizumab preconditioning followed by etoposide and cisplatin regimen in human epidermal growth factor receptor-2-positive breast cancer brain metastasis refractory to whole brain radiotherapy. Journal of Cancer Research & Practice, 10(1), 11. https://doi.org/10.4103/ejcrp.eJCRP-D-23-00001

Chicago Style (17th ed.) Citation

Chen, Tom, et al. "Anti-tumor Efficacy of a Bevacizumab Preconditioning Followed by Etoposide and Cisplatin Regimen in Human Epidermal Growth Factor Receptor-2-positive Breast Cancer Brain Metastasis Refractory to Whole Brain Radiotherapy." Journal of Cancer Research & Practice 10, no. 1 (2023): 11. https://doi.org/10.4103/ejcrp.eJCRP-D-23-00001.

MLA (9th ed.) Citation

Chen, Tom, et al. "Anti-tumor Efficacy of a Bevacizumab Preconditioning Followed by Etoposide and Cisplatin Regimen in Human Epidermal Growth Factor Receptor-2-positive Breast Cancer Brain Metastasis Refractory to Whole Brain Radiotherapy." Journal of Cancer Research & Practice, vol. 10, no. 1, 2023, p. 11, https://doi.org/10.4103/ejcrp.eJCRP-D-23-00001.